Fujitsu Frontech North America Inc. Completes Acquisition of Fulcrum Biometrics, LLC
The acquisition will allow Fujitsu Frontech North America Inc. to strengthen its offerings and expand…
6 years ago
Plarium Releases Casual Adventure Game ‘Undersea Solitaire Tripeaks’ on Mobile
First-To-Market Game that fuses Solitaire with a Narrative-Driven Adventure TEL AVIV, Israel--(BUSINESS WIRE)--Plarium, a leading…
6 years ago
MCI Expands Metals, Minerals and Mining Sector Consulting Capabilities Through Merger with Saint Barbara
MCI joins forces with Saint Barbara to offer clients a broad range of metals, minerals…
6 years ago
Future Armoured Vehicles Weapon Systems 2020 Will Now be Remote Access Only, Due to COVID-19 Concerns
SMi Reports: Future Armoured Vehicles Systems 2020 will be held as a virtual conference, following…
6 years ago
Ocasta Launch Free Scanning App to Reduce the Spread of COVID-19 and Keep GDPR Compliant
Ocasta, are an agency who are on a mission to transform how people work through…
6 years ago
Celanese Supports Customers and Medical Equipment Manufacturers Battling COVID-19 Pandemic
DALLAS, AMSTERDAM & SHANGHAI--(BUSINESS WIRE)--$CE #Celanese--Celanese Corporation (NYSE: CE), a global chemical and specialty materials…
6 years ago
India E-Commerce Packaging Market Projected to Reach USD 975.4 Million by 2025 with a CAGR of 13.8% – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "India E-Commerce Packaging Market - Growth, Trends and Forecasts (2020 - 2025)" report…
6 years ago
Trinity Limited Under Ruyi Group Increases Its Revenue by 13.9% In 2019
HONG KONG--(BUSINESS WIRE)--Trinity Limited (0891.HK), a subsidiary company of Ruyi Group (002193.SH), announced its 2019…
6 years ago
BrainChip Introduces Company’s Event-Based Neural-Network IP and NSoC Device at Linley Processor Virtual Conference
AKD1000 is the first event-based processor for Edge AI with ultra-low power consumption and continuous…
6 years ago
Noxopharm Investigating Potential COVID-19 Treatment
SYDNEY--(BUSINESS WIRE)--#clinicaltrials--Noxopharm, a clinical-stage Australian oncology drug development company, has identified a clinical trial opportunity…
6 years ago